Genome research receives major funding related to health, agriculture and environmental projects while Canadian Nuclear Labs pursue clean energy technologies for marine operations in Canada and internationally.
Topic: pharmaceutical sector
On August 7, the deadline closed for submissions to the pre-budget consultations process ahead of the 2021 federal budget, and Canadian organizations have been publishing their recommendations and suggestions.
The commercialization organization formerly known as MaRS Innovation announced a new collaboration with the biotechnology company Amgen, to identify and jointly fund disruptive technologies derived from discovery research conducted in Toronto.
Charlottetown, PEI-based life sciences company BioVectra Inc. announced a five-year project to support and expand its production capacity in Atlantic Canada.
The National Research Council is embarking on a re-alignment of its core strengths by reaching out to academia and other players in the federal innovation system (see lead article). NEOMED is making major strides retaining critical pharmaceutical talent in the Montreal region and its actively considering a third site for its potent combination of research expertise and business collaboration